Nine clinical trials on cannabis for insomnia returned largely disappointing results — but the science is far from settled.

A new US federal study finds cancer patients using medical cannabis report fewer symptoms and lower opioid use — findings with real implications for European palliative care.

A newly approved clinical trial testing a THC-based medication for chronic sciatica marks a milestone in cannabis pain research with implications well beyond one jurisdiction.

A large U.S. federal study adds to the growing clinical evidence base for medical cannabis in oncology — with implications for European prescribing frameworks.

A large study of 637,000 adolescents suggests self-reported use data may undercount clinically diagnosed cannabis use disorder among young people.

A Swiss pilot study adds to a growing body of evidence that regulated cannabis markets reduce harm rather than increase it.

New neuroimaging research suggests cannabis use alters nicotine processing in the brain — with implications for dual-use consumers across Europe.

Researchers are increasingly asked whether occasional cannabis use is safe. The honest answer is more nuanced than either camp wants to admit.